Navigation Links
Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System
Date:9/8/2009

CENTENNIAL, Colo., Sept. 8 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, announced today that the U.S. Food and Drug Administration (FDA) has approved the Nucleus((R) )5 System for adults and children with severe-to-profound hearing loss. Working with leading surgeons and audiologists worldwide, Cochlear has developed the most advanced technology including a smaller and thinner device with an unparalleled capability to deliver superior hearing performance and better user comfort. The Nucleus 5 System is the only one of its kind on the market today that offers the smallest, most water resistant sound processor, the thinnest titanium cochlear implant, two-way remote assistant, SmartSound((TM)) 2 technology and AutoPhone((TM)) capability.

Cochlear implants have the ability to restore hearing for individuals who are severely hard of hearing or profoundly deaf and who receive limited to no benefit from hearing aids. The new Nucleus 5 System is the most advanced cochlear implant system on the market for all ages*, which includes powerful features designed to restore hearing in deaf children so that they have the greatest potential to develop the spoken language skills necessary for school. Adults will benefit from advanced features that deliver the best listening options for phone use, communication in noisy environments and music enjoyment.

"Cochlear has reached a significant milestone with the introduction of the Nucleus 5 System. We have built upon our industry-leading hearing performance and reliability record with new, unique features designed to give users greater flexibility and help them hear better in difficult situations. We celebrate this milestone with the dedicated clinicians who have helped us positively impact the lives of so many people," said Chris Smith, President of Cochlear Americas.

Nucleus 5 System Delivers the Best Hearing Performanc
'/>"/>

SOURCE Cochlear Americas
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cochlear Americas Announces FDA Clearance of the Cochlear(TM) Baha(R) BP100 Sound Processor, the Industrys First Programmable Bone Conduction Hearing Solution
2. Cochlear Americas Hosts Celebration 2009 for Cochlear Implant Recipients and Their Families
3. NYU Langone Medical Center study shows that cochlear implant surgery is safe for the elderly
4. Bilateral cochlear implants: A case when 2 are definitely superior to 1
5. Cochlear implant recipients experience improvement in quality of life
6. Design of a new system that improves hearing in patients who carry a cochlear implant
7. Cochlear Americas Announces 2008 Graeme Clark Scholarship Winners
8. Neural Insights Could Bring Better Cochlear Implants
9. Bill Johnstone Named Senior Vice President of Crawfords Global Technical Services for the Americas
10. Preparing the Americas: The Outlook for 2009s Emergency Threats
11. AmericaSpeakOn.org Exclusive: Leavitt Asks How Prepared Is the US for the Swine Flu Pandemic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... August 03, 2015 , ... BESLER Consulting today announced ... Awards. , The MarketingProfs Bright Bulb B2B Awards celebrate the best marketing, communications, ... the launch of their Readmissions Analytics product was selected as one of four ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today welcomed ... accepted for review OPKO’s New Drug Application for a new treatment for chronic ...
(Date:8/3/2015)... , ... August 03, 2015 , ... The art of ... Learning from her grandmother’s side at a young age, Nasreen Zereshki was extremely eager ... decided to share her cookbook Recipes from My Persian Kitchen with the world. , ...
(Date:8/3/2015)... ... 2015 , ... The U.S. Food and Drug Administration (FDA) recently approved a ... acid, which occurs naturally in the body and helps absorb and breakdown fat cells. ... the body. These are invasive procedures and very expensive for most people. Now with ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Dignity Health ... Health Arizona General Hospital Emergency Room – Gilbert, opening in August. The new ... this year in the West Valley. , “Dr. Baldwin is an excellent leader ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3
... http://www.himfr.com/hot-products/ ), one of China,s leading B2B search,platforms ... name, recommends five,kinds of foods to eat in spring. ... Cherry ( http://www.himfr.com/buy-cherry/ ) has ... 20 times that of an apple,( http://www.himfr.com/buy-apple/ ...
... will feature the nation,s health care leaders for an in-depth ... under the Obama administration to new technologies and practices that ... Health Care Congress in Washington D.C. is a unique gathering ... provides a forum for the most recent insights on health. ...
... Industries, Inc. (Nasdaq: HRLY ) announced today that ... $1 million from the U. S. Air Force for the ... The awards are for the production of transmit microwave assemblies ... components for use in the APG-68 radar system on various ...
... Product Launch to Include 24-oz and Convenient 4-oz ... PURE Bioscience (Nasdaq: PURE ) today ... distribution of PURE,s silver dihydrogen citrate (SDC)-based disinfectant ... Sterifide Laboratories, OneShot Plus product line. OneShot ...
... Mass., March 2 Boston Scientific Corporation (NYSE: ... has elected John E. Sununu as a Director. For ... Senator from New Hampshire. He was a member of ... he was appointed the Congressional Representative to the United Nations ...
... from TV viewing by young children, , , MONDAY, March 2 (HealthDay ... of videos claiming to be educationally stimulating for babies, you might ... A new study suggests that watching television won,t improve a baby,s ... day. , "TV, in and of itself, doesn,t seem to ...
Cached Medicine News:Health News:Himfr.com Recommends Five Foods for Spring 2Health News:World Health Care Congress to convene preeminent leaders for 3 days on rebuilding health care 2Health News:Herley Lancaster Awarded $1.0 Million in New Contracts 2Health News:Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer 2Health News:Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer 3Health News:Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer 4Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 2Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 4Health News:TV Watching Doesn't Fast-Track Baby's Skills 2Health News:TV Watching Doesn't Fast-Track Baby's Skills 3
(Date:8/3/2015)... SAN FRANCISCO , August 3, 2015 /PRNewswire/ ... size is expected to reach USD 24.7 ... by Grand View Research Inc. Growing prevalence of ... the physiotherapy equipments market over the forecast period. ... as ultrasound and cryotherapy, advancement in the technologies ...
(Date:8/3/2015)... , Aug. 3, 2015  Dr. ... Orthopaedic & Spine Center today, providing ... manage their chronic pain through psychological counseling and ... is a Fellowship-trained, certified medical psychologist with an ... His vast experience ranges from assessment and treatment ...
(Date:8/3/2015)... Corporation (NASDAQ: CYTR ), a biopharmaceutical research and ... for the three months ended June 30, 2015, and ... milestones for its clinical development programs. "The ... CytRx. Enrollment in our ongoing pivotal global Phase 3 ... continues on track to be completed in the first ...
Breaking Medicine Technology:Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Orthopaedic & Spine Center Introduces New Pain Psychologist 2CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14
... Oct. 19, 2011  CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical ... Adhesion Kinase (FAK) inhibitors for cancer, announced today that ... present a company overview at the Biotechnology Industry Organization,s ... Francisco, CA on Wednesday, October 26 at 9:00 am. ...
... Oct. 19 2011 Varian Medical Systems (NYSE: ... X-Ray imaging technology, is announcing the publication of its ... company,s policies and achievements in extending care, protecting resources ... has been produced as part of the wider investment ...
Cached Medicine Technology:CureFAKtor Pharmaceuticals to Present at 10th Annual BIO Investor Forum 2Varian Medical Systems Publishes First Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements 2
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
HDL Cholesterol (PEG) Precip. Reagent + 5 ml of 50 mg/dl cholesterol std....
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
... Intended for the quantitative ... plasma. Two vials, dry ... alphaketoglutarate. Uses NADPH to ... plasma compounds. Reaction: Enzymatic, ...
Medicine Products: